We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC.PRL icon
726
Bank of America Series L
BAC.PRL
$4.02B
$12.8M 0.02%
8,634
-1,080
-11% -$1.58M
HOLX
727
DELISTED
Hologic
HOLX
$12.8M 0.02%
192,310
+87,587
+84% +$5.54M
AGZ icon
728
iShares Agency Bond ETF
AGZ
$565M
$12.8M 0.02%
105,554
-40,045
-28% -$4.86M
CRNC icon
729
Cerence
CRNC
$384M
$12.8M 0.02%
261,307
+13,576
+5% +$652K
SSNC icon
730
SS&C Technologies
SSNC
$18.7B
$12.8M 0.02%
210,869
-13,939
-6% -$834K
IMCG icon
731
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.16B
$12.8M 0.02%
238,752
+147,210
+161% +$7.67M
DWAS icon
732
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$452M
$12.7M 0.02%
214,443
+6,753
+3% +$390K
OKE icon
733
Oneok
OKE
$57.7B
$12.7M 0.02%
489,841
-374,075
-43% -$10.4M
SOXX icon
734
iShares Semiconductor ETF
SOXX
$46.6B
$12.7M 0.02%
124,689
+13,752
+12% +$1.34M
EG icon
735
Everest Group
EG
$14B
$12.6M 0.02%
63,966
+2,795
+5% +$598K
HQY icon
736
HealthEquity
HQY
$8.82B
$12.6M 0.02%
245,937
-37,809
-13% -$2.08M
IDLV icon
737
Invesco S&P International Developed Low Volatility ETF
IDLV
$344M
$12.5M 0.02%
440,774
-47,319
-10% -$1.34M
AVT icon
738
Avnet
AVT
$8.04B
$12.5M 0.02%
485,424
+187,801
+63% +$5.09M
KMX icon
739
CarMax
KMX
$8.25B
$12.5M 0.02%
136,241
+9,865
+8% +$985K
WTRG icon
740
Essential Utilities
WTRG
$11.3B
$12.5M 0.02%
309,729
+52,588
+20% +$2.26M
FICO icon
741
Fair Isaac
FICO
$22.2B
$12.4M 0.02%
29,164
+4,954
+20% +$2.1M
MKL icon
742
Markel Group
MKL
$22.9B
$12.4M 0.02%
12,731
-7,339
-37% -$7.45M
TD icon
743
Toronto Dominion Bank
TD
$203B
$12.3M 0.02%
265,726
+11,617
+5% +$541K
VCR icon
744
Vanguard Consumer Discretionary ETF
VCR
$6.1B
$12.3M 0.02%
52,347
+542
+1% +$123K
APH icon
745
Amphenol
APH
$211B
$12.2M 0.02%
450,028
+9,396
+2% +$248K
PUK icon
746
Prudential
PUK
$34.1B
$12.2M 0.02%
438,666
+4,812
+1% +$144K
FAST icon
747
Fastenal
FAST
$60B
$12.2M 0.02%
539,372
-863,206
-62% -$19.8M
HCA icon
748
HCA Healthcare
HCA
$89.2B
$12.2M 0.02%
97,448
-2,101
-2% -$260K
ET icon
749
Energy Transfer Partners
ET
$71.8B
$12.1M 0.02%
2,237,282
-250,571
-10% -$1.59M
EA
750
DELISTED
Electronic Arts
EA
$12.1M 0.02%
92,685
+5,798
+7% +$790K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.